While IGSF11 shows minimal expression in normal tissues, recent studies show that it is significantly upregulated in various cancers, such as colorectal cancer, hepatocellular carcinoma, melanoma [19], gastric cancer [20], and breast cancer [21]. Here, IGSF11 is linked to gastric cancer.